4P-Pharma aims to bring to patients’ curative solutions faster by :

• Building scientific approaches, linking innovative cellular target to disease biology
• Leveraging on regulatory fast track to target large unmet medical needs
• Mitigating risk path to market access through SPV incorporation and big pharma collaborations.​

Funding: Looking for Serie A ($40 M)